Literature DB >> 29366411

Effects of GHB On Psychomotor and Driving Performance.

Carmela Centola1, Arianna Giorgetti1, Simona Zaami1, Raffaele Giorgetti1.   

Abstract

BACKGROUND: Gamma-hydroxybutyrate (γ-hydroxybutyrate or GHB) is a physiological compound of mammalians with specific receptors in central nervous system (CNS). Apart from an endogenous production, GHB is also an exogenous molecule found in pharmaceutical as well as in illicit formulations. Products manufactured and spread in these two fields, whose borders are all but strictly defined and traced, differ for the in vivo effects and for the potential of abuse. Illicit GHB gained public attention due to its use as a sexual assault facilitator. Notwithstanding its popularity, the effects on human performances, are still not completely understood and could be more complex than expected. Therefore, there is a real public safety concern regarding psychomotor functions and driving abilities due to GHB ingestion.
OBJECTIVE: To provide an updated and complete review on the effects of GHB on psychomotor, cognitive and driving performance that may be useful for judiciary expert forensic evaluation of driving under the influence of GHB (GHB-DUI).
METHOD: Experimental animal-based and human-based studies and case series or epidemiological studies regarding driving under influence of GHB (and its precursors) were reviewed using main scientific databases.
RESULTS: The effects of GHB on cognitive, psychomotor and driving performance are dose-related in experimental studies. In real cases of driving under the influence of GHB, severe impairment is observed. In these cases, a wide range of blood GHB levels are found. Possible long-term effects are also reported.
CONCLUSION: GHB causes cognitive and psychomotor impairment and risky driving behavior. Multiple aspects and variables are still waiting clarification, such as the harmful potential of illicit preparations, the effect of precursors and impairing dosages. GHB (and its precursors) must be considered a substantial personal and public risk even in the absence of a clear dose-effects correlation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  GHB; cognitive performance; driving safety; driving skills; psychomotor performance; γ-hydroxybutyrate.

Mesh:

Substances:

Year:  2018        PMID: 29366411     DOI: 10.2174/1389200219666180124113802

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  4 in total

1.  Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.

Authors:  Evangelia Liakoni; Delia A Dempsey; Matthew Meyers; Nancy G Murphy; Dary Fiorentino; Christopher Havel; Christine Haller; Neal L Benowitz
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

2.  Comparison of N-methyl-2-pyrrolidone (NMP) and the "date rape" drug GHB: behavioral toxicology in the mouse model.

Authors:  Raffaella Arfè; Sabrine Bilel; Micaela Tirri; Paolo Frisoni; Giovanni Serpelloni; Margherita Neri; Federica Boccuto; Tatiana Bernardi; Federica Foti; Fabio De-Giorgio; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2021-04-21       Impact factor: 4.530

Review 3.  Toxicological Characterization of GHB as a Performance-Enhancing Drug.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

4.  Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving.

Authors:  Vasco Orazietti; Giuseppe Basile; Raffaele Giorgetti; Arianna Giorgetti
Journal:  Front Psychiatry       Date:  2022-09-26       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.